Publicações

Subgroup Analysis of the Phase Ii Randomized Mcl-002 (Sprint) Study of Lenalidomide Vs Investigator's Choice in Relapsed/Refractory Mantle Cell Lymphoma

AuthID
P-00G-EW8

Author(s)

Trneny, M

Lamy, T

Walewski, JA

Belada, D

Mayer, J

Radford, JA

Jurczak, W

Morschhauser, F

Alexeeva, J

Rule, S

Biyukov, TN

Patturajan, M

Bravo, MLC

Cabecadas, J

Arcaini, L

Group Author(s)

SPRINT Trial Investigators

Tipo de Documento

Abstract

Year published

2015

Publicado

in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X

Volume: 33, Número: 15

Conference

Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: MAY 29-JUN 02, 2015, Location: Chicago, IL, Patrocinadores: Amer Soc Clin Oncol

Indexing

Wos^®

Metadata
Fontes

Publication Identifiers

Wos: WOS:000358036901859

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Subgroup Analysis of the Phase Ii Randomized Mcl-002 (Sprint) Study of Lenalidomide Vs Investigator's Choice in Relapsed/Refractory Mantle Cell Lymphoma

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Subgroup Analysis of the Phase Ii Randomized Mcl-002 (Sprint) Study of Lenalidomide Vs Investigator's Choice in Relapsed/Refractory Mantle Cell Lymphoma

Links Úteis

Ajuda